European Society For Medical Oncology said it will take over the organization of the Targeted Anticancer Therapies Congress, with the aim of expanding its educational offer and ensure that professionals are kept up-to-date with the latest drug developments to improve outcomes for cancer patients.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe